Pretreatment FDG-PET Metrics in Stage III Non–Small Cell Lung Cancer: ACRIN 6668/RTOG 0235

BACKGROUND: ACRIN 6668/RTOG 0235 evaluated the prognostic value of positron emission tomography with (18)F-fluorodeoxyglucose (FDG-PET) uptake before and after definitive, concurrent, platinum-based chemoradiotherapy for locally advanced non–small cell lung cancer (NSCLC). In this secondary analysis...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Natl Cancer Inst
Asıl Yazarlar: Ohri, Nitin, Duan, Fenghai, Machtay, Mitchell, Gorelick, Jeremy J., Snyder, Bradley S., Alavi, Abass, Siegel, Barry A., Johnson, Douglas W., Bradley, Jeffrey D., DeNittis, Albert, Werner-Wasik, Maria
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402361/
https://ncbi.nlm.nih.gov/pubmed/25688115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv004
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller